You are warmly invited to the Mini‑Symposium of the Polish Lipidology Society (PTL) and the International Lipid Expert Panel (ILEP) during the 35th Congress of the European Society of Hypertension, taking place in Gdańsk. The symposium’s theme is “Beyond Blood Pressure: A Multirisk, Multimorbidity Strategy for Cardiovascular Prevention — Visions for 2026 and Beyond.” We […]

We partnered with the 200th Samobor Carnival (Samoborski fašnik) — one of the largest and most traditional public events in Croatia — transforming a major cultural gathering into a platform for cardiometabolic prevention. Key highlights of the initiative: 🔹 Around 30 medical students participated as symbolic “demons and hunters,” creatively representing the fight against hypertension, […]

It was a great pleasure to announce that our colleague Lokman H. Tanriverdi, MD, PhD received the 2026 Prof. Dr. R. Kazım Türker Young Pharmacologist Incentive Award at the 34th Prof. Dr. Alaeddin Akcasu Pharmacology Education – Intergenerational Scientific Interaction Symposium (FEKBES), organized by the Turkish Pharmacological Society on February 12–14, 2026. This award recognizes a […]

On 29th of January we hosted an outstanding meeting held under the auspices of the International Lipid Expert Panel (ILEP), the European Program for Prevention (EPP, www.epprevention.eu), and the KUL, The John Paul II Catholic University of Lublin! The event was honoured by numerous guests from across Europe who play key roles in shaping healthcare policy, including: […]

Lublin and KUL Warm Welcome Welcome message and main information on the Summit EU Safe Hearts Plan – prevention as the main strategy in the fight against CVDs! Public Health as an effective tool in CVD prevention in Europe. The European Program for Prevention – how to strengthen CEE Members States voices in the European […]

Very briefly:1️⃣ Together with Prof. Carlos Escobar and with ILEP as a consortium member, we have just submitted an EU grant on AI applications in CVD medicine for rare and underrepresented diseases. Keep your fingers crossed 👍 2026 is sure to be a year of grants‼️2️⃣ We’re pleased to welcome two new ILEP members: Dr. […]

Lublin Prevention in Cardiovascular Disease SUMMIT 2026 under the umbrella of the International Lipid Expert Panel (ILEP) and the John Paul II Catholic University of Lublin (KUL) 29th January 2026 08:30 – 08:45 Registration, Coffee and Networking 08:45 – 09:00 Lublin and KUL Warm Welcome Prof. Miroslaw Kalinowski (Rector of the KUL) 09:00 – 09:15 […]

Finally, the first and the largest #metaanalysis on the upfront combination lipid lowering therapy (#LLT) of moderate to high intensity #statin therapy and #ezetimibe vs statin monotherapy has been released in the Mayo Clinic Proceedings by Elsevier. Based on the data from 14 studies with 108,373 very high-risk #patients we showed that #combination LLT:👉 significantly […]

The European Program for Prevention (www.epprevention.eu), which we officially launched on June 4 in Warsaw, has been published in the Global Heart, the official journal of the World Heart Federation. The EPP offers clear, practical prevention solutions from Central and Eastern Europe (CEE) that can be readily adopted elsewhere. It is a tool that can […]

Another important International Lipid Expert Panel (ILEP) #metaanalysis on #therapy for homozygous familial #hypercholesterolemia (#HoFH) has just been published in #Drugs (IF = 14.4) by Springer Nature. Excellent work by Prof. Ibadete Bytyçi — ILEP’s Statistical Lead — and the Kosovo team! This is crucial because HoFH remains severely underdiagnosed and is often identified too […]